Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
21677 | 352 | 30.6 | 75% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | PROTHROMBIN COMPLEX CONCENTRATE | Author keyword | 27 | 42% | 14% | 50 |
2 | PROTHROMBIN COMPLEX CONCENTRATES | Author keyword | 23 | 42% | 12% | 43 |
3 | ANTICOAGULATION REVERSAL | Author keyword | 12 | 63% | 3% | 12 |
4 | WARFARIN REVERSAL | Author keyword | 8 | 75% | 2% | 6 |
5 | HEMOPHILIA CRIT CARE | Address | 4 | 75% | 1% | 3 |
6 | OCTAPLEX | Author keyword | 4 | 75% | 1% | 3 |
7 | ORAL ANTICOAGULANT REVERSAL | Author keyword | 3 | 100% | 1% | 3 |
8 | PHYTOMENADIONE | Author keyword | 3 | 35% | 2% | 6 |
9 | PHYTONADIONE | Author keyword | 2 | 32% | 2% | 6 |
10 | VITAMIN K ANTAGONIST REVERSAL | Author keyword | 2 | 67% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PROTHROMBIN COMPLEX CONCENTRATE | 27 | 42% | 14% | 50 | Search PROTHROMBIN+COMPLEX+CONCENTRATE | Search PROTHROMBIN+COMPLEX+CONCENTRATE |
2 | PROTHROMBIN COMPLEX CONCENTRATES | 23 | 42% | 12% | 43 | Search PROTHROMBIN+COMPLEX+CONCENTRATES | Search PROTHROMBIN+COMPLEX+CONCENTRATES |
3 | ANTICOAGULATION REVERSAL | 12 | 63% | 3% | 12 | Search ANTICOAGULATION+REVERSAL | Search ANTICOAGULATION+REVERSAL |
4 | WARFARIN REVERSAL | 8 | 75% | 2% | 6 | Search WARFARIN+REVERSAL | Search WARFARIN+REVERSAL |
5 | OCTAPLEX | 4 | 75% | 1% | 3 | Search OCTAPLEX | Search OCTAPLEX |
6 | ORAL ANTICOAGULANT REVERSAL | 3 | 100% | 1% | 3 | Search ORAL+ANTICOAGULANT+REVERSAL | Search ORAL+ANTICOAGULANT+REVERSAL |
7 | PHYTOMENADIONE | 3 | 35% | 2% | 6 | Search PHYTOMENADIONE | Search PHYTOMENADIONE |
8 | PHYTONADIONE | 2 | 32% | 2% | 6 | Search PHYTONADIONE | Search PHYTONADIONE |
9 | VITAMIN K ANTAGONIST REVERSAL | 2 | 67% | 1% | 2 | Search VITAMIN+K+ANTAGONIST+REVERSAL | Search VITAMIN+K+ANTAGONIST+REVERSAL |
10 | ANTIVITAMINS K | 1 | 50% | 1% | 2 | Search ANTIVITAMINS+K | Search ANTIVITAMINS+K |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PHYTONADIONE | 60 | 83% | 10% | 34 |
2 | EXCESSIVE ANTICOAGULATION | 46 | 60% | 14% | 50 |
3 | EMERGENCY REVERSAL | 29 | 75% | 6% | 21 |
4 | INTRAVENOUS PHYTONADIONE VITAMIN K 1 | 27 | 92% | 3% | 11 |
5 | ORAL ANTICOAGULANT REVERSAL | 27 | 65% | 7% | 26 |
6 | WARFARIN REVERSAL | 27 | 62% | 8% | 28 |
7 | URGENT REVERSAL | 24 | 82% | 4% | 14 |
8 | RAPID REVERSAL | 20 | 58% | 7% | 23 |
9 | ADVERSE SKIN REACTION | 15 | 88% | 2% | 7 |
10 | WARFARIN ASSOCIATED COAGULOPATHY | 12 | 58% | 4% | 14 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
A systematic review of prothrombin complex concentrate dosing strategies to reverse vitamin K antagonist therapy | 2015 | 3 | 34 | 79% |
Systematic review: 3-factor versus 4-factor prothrombin complex concentrate for warfarin reversal: Does it matter? | 2012 | 11 | 29 | 83% |
Prothrombin complex concentrates: an update | 2010 | 39 | 35 | 71% |
Prothrombin complex concentrates in emergency bleeding disorders | 2012 | 12 | 39 | 72% |
Clinical review: Prothrombin complex concentrates - evaluation of safety and thrombogenicity | 2011 | 69 | 48 | 50% |
Prothrombin complex concentrates: a brief review | 2008 | 52 | 27 | 81% |
Prothrombin Complex Concentrates for Oral Anticoagulant Therapy-Related Intracranial Hemorrhage: A Review of the Literature | 2010 | 42 | 62 | 52% |
Treatment of coumarin-associated coagulopathy: a systematic review and proposed treatment algorithms | 2006 | 60 | 50 | 76% |
USE OF FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE IN THE EMERGENCY DEPARTMENT: A REVIEW | 2015 | 1 | 17 | 29% |
Prothrombin complex concentrate for the urgent reversal of warfarin. Assessment of a standard dosing protocol | 2012 | 5 | 24 | 71% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HEMOPHILIA CRIT CARE | 4 | 75% | 0.9% | 3 |
2 | BLOOD BLANK | 1 | 50% | 0.3% | 1 |
3 | CHAIR CARDIO THORAC SURG | 1 | 50% | 0.3% | 1 |
4 | CLIN AUSTIN | 1 | 50% | 0.3% | 1 |
5 | CLIN PHARM NEUROL NEUROSURG | 1 | 50% | 0.3% | 1 |
6 | COLUMBIA UNIV PHYS SURGMED | 1 | 50% | 0.3% | 1 |
7 | EMERGENCY MED TRAINING PROGRAM | 1 | 50% | 0.3% | 1 |
8 | GUYS ST THOMAS HOSP NHS TRUST FDN MED | 1 | 50% | 0.3% | 1 |
9 | SERV AIDE MED URGENTE 77 | 1 | 50% | 0.3% | 1 |
10 | TRANSFUS MED SERV GRP | 1 | 50% | 0.3% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000218094 | INTERNATIONAL SENSITIVITY INDEX//PROTHROMBIN TIME//INTERNATIONAL NORMALIZED RATIO |
2 | 0.0000195029 | RIVAROXABAN//DABIGATRAN//APIXABAN |
3 | 0.0000182428 | INTRACEREBRAL HEMORRHAGE//HEMATOMA EXPANSION//SPOT SIGN |
4 | 0.0000162974 | RFVIIA//RECOMBINANT ACTIVATED FACTOR VII//RECOMBINANT FACTOR VIIA |
5 | 0.0000156466 | BRIDGING ANTICOAGULATION//BRIDGING THERAPY//BLOOD THINNERS |
6 | 0.0000156083 | MASSIVE TRANSFUSION//THROMBOELASTOMETRY//THROMBOELASTOGRAPHY |
7 | 0.0000116441 | CYP2C9//VKORC1//WARFARIN |
8 | 0.0000091055 | MEYERSON PHENOMENON//MEYERSONS NEVUS//HALO DERMATITIS |
9 | 0.0000087986 | ATRIAL FIBRILLATION//WARFARIN//CITY HOSP |
10 | 0.0000085657 | MINOR HEAD INJURY//PROGRESSIVE HEMORRHAGIC INJURY//NEUROSURGICAL INTERVENTION |